NeoBio – Peptide & Oligonucleotide Consultation Services

At NeoBio, we provide specialized consulting in peptide formulation development and analytical characterization. Peptide therapeutics demand more than routine analysis and require strategic study design, expert data interpretation, and regulatory‑ready documentation. Our consulting services help you navigate complexity, strengthen scientific rigor, and prepare your programs for successful regulatory submission.

We deliver high‑quality peptide and oligonucleotide impurities and standards that meet the most rigorous global benchmarks. Trusted by scientists and research institutions worldwide, our materials ensure reliability, consistency, and confidence in discovery.

NeoBio combines dependable standards with regulatory expertise — empowering innovation while ensuring compliance.

Lab-grade assurance

  • Peptide and Oligonucleotide impurities standards.
  • Consultation on Peptide formulation & Analytical development.
  • Contract service provider identification and evaluation.
  • Scientific Writing.

Why choose us

At NeoBio, we combine scientific rigor with regulatory expertise to support research teams worldwide.

Together, these strengths make NeoBio the trusted partner for advancing peptide and oligonucleotide innovation with confidence and precision.

Impurities & Standards

From peptide impurities to oligonucleotide standards, we deliver uncompromising quality assurance backed by expert scientific guidance.

Product Development and characterization

Strong expertise in formulation development and analytical characterization ensures robust, reliable outcomes.

Regulatory Alignment

Consulting tailored to FDA, EMA, and ICH expectations keeps your projects compliant and future‑ready.

Data-Driven Decisions

We transform complex datasets into actionable insights that accelerate innovation.

Scientific Writing Excellence

Regulatory‑ready reports and dossiers communicate your results with clarity, authority, and impact.

Our vision

At NeoBio, we aspire to be the trusted global partner for scientists, researchers, and pharmaceutical companies. We unite scientific guidance with quality assurance to deliver peptide and oligonucleotide standards that meet the highest regulatory expectations.

Our vision is to simplify complex development journeys by providing end-to-end CMC consulting, Study design, strategic support for API and drug product stability, and expert guidance in impurity identification and characterization and scientific writing.

We empower our partners with consulting in formulation process development.

We provide strategic support in contract service provider identification, request for proposal management, and tech transfer consulting.

Call to Action

Explore our catalog today and discover how NeoBio can support your research and development journey. Together, we can shape the future of peptide and oligonucleotide therapeutics.